Published by PM360 – August 9, 2017 The growing power of payers in healthcare decision-making has put an increased emphasis on health economics and outcomes research (HEOR), as the data collected through that research is key to demonstrating the value of your drug. As HEOR teams have grown in importance, their roles have expanded to[…]
On this webinar, Dr. Richard Gliklich, CEO of OM1, discussed the evolving role of big data and cognitive computing in generating real-world evidence for cardiovascular and metabolic diseases. This session explored how innovative methodologies and technologies can be applied to support safety, value, and commercial strategies. Topics covered included: New real-world evidence methodologies and approaches[…]
The needs for real-world evidence continue to grow, but so have the tools. This session will explore the changes in technology, data liquidity, healthcare economics and how they are all combining to change the needs for real-world evidence and the best means to collect, analyze and use it. While registries remain an important component of[…]
